These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30929534)

  • 21. Surgical approaches to hemophilic arthropathy.
    Rodriguez-Merchan EC
    Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S11-S13. PubMed ID: 31517710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Our experience with orthopedic surgery in hemophiliacs.
    Poenaru DV; Serban M; Branea IL; Pătraşcu JM
    Srp Arh Celok Lek; 2006; 134(3-4):143-50. PubMed ID: 16915756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemophilic arthropathy of the knee joint. Treatment of hemorrhages of the knee-joint and their consequences].
    Landbeck G; Kurme A
    Monatsschr Kinderheilkd (1902); 1970 Feb; 118(2):29-41. PubMed ID: 5522402
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy.
    Gregosiewicz A; Wośko I; Kandzierski G
    J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures.
    Schild FJ; Mauser-Bunschoten EP; Verbout AJ; Van Rinsum AC; Roosendaal G
    J Thromb Haemost; 2009 Oct; 7(10):1741-3. PubMed ID: 19682237
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
    Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
    Ovlisen K; Kristensen AT; Valentino LA; Hakobyan N; Ingerslev J; Tranholm M
    J Thromb Haemost; 2008 Jun; 6(6):969-75. PubMed ID: 18363814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
    Barthels M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in hemophilia: experimental aspects and therapy.
    Rodriguez NI; Hoots WK
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):181-98. PubMed ID: 20113902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synovitis in hemophilia: preventing, detecting, and treating joint bleeds.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2023; 16(7):525-534. PubMed ID: 37119182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
    Teitel JM; Carcao M; Lillicrap D; Mulder K; Rivard GE; St-Louis J; Smith F; Walker I; Zourikian N
    Haemophilia; 2009 Jan; 15(1):227-39. PubMed ID: 18752535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophilia in Iran.
    Dorgalaleh A; Dadashizadeh G; Bamedi T
    Hematology; 2016 Jun; 21(5):300-10. PubMed ID: 26914731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthopedic management of hemophilia.
    Heyworth BE; Su EP; Figgie MP; Acharya SS; Sculco TP
    Am J Orthop (Belle Mead NJ); 2005 Oct; 34(10):479-86. PubMed ID: 16304795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synovectomy of the knee for hemophilic arthropathy.
    Montane I; McCollough NC; Lian EC
    J Bone Joint Surg Am; 1986 Feb; 68(2):210-6. PubMed ID: 3944160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophilic arthropathy: Current knowledge and future perspectives.
    Gualtierotti R; Solimeno LP; Peyvandi F
    J Thromb Haemost; 2021 Sep; 19(9):2112-2121. PubMed ID: 34197690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic treatment in hemophilic patients with inhibitors.
    Haya S
    Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S14-S18. PubMed ID: 31517711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovectomy in the treatment of hemophilic arthropathy.
    Dyszy-Laube B; Kaminski W; Gizycka I; Kaminska D; Sekowska-Zmuda J; Ludert E
    J Pediatr Surg; 1974 Feb; 9(1):123-5. PubMed ID: 4811249
    [No Abstract]   [Full Text] [Related]  

  • 40. EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
    Magisetty J; Pendurthi UR; Esmon CT; Rao LVM
    Blood; 2020 Jun; 135(25):2211-2223. PubMed ID: 32294155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.